Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP399862.RAC4qxOCHeZ5jmmQUifTGU_vXkVIRGLfAv5o5fDwoMZPM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP399862.RAC4qxOCHeZ5jmmQUifTGU_vXkVIRGLfAv5o5fDwoMZPM130_assertion type Assertion NP399862.RAC4qxOCHeZ5jmmQUifTGU_vXkVIRGLfAv5o5fDwoMZPM130_head.
- NP399862.RAC4qxOCHeZ5jmmQUifTGU_vXkVIRGLfAv5o5fDwoMZPM130_assertion description "[The crystal structure, of Pro252Arg FGFR1c in complex with FGF2, demonstrates that the enhanced ligand binding is due to an additional set of receptor-ligand hydrogen bonds, similar to those gain-of-function interactions that occur in the Apert syndrome Pro253Arg FGFR2c-FGF2 crystal structure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP399862.RAC4qxOCHeZ5jmmQUifTGU_vXkVIRGLfAv5o5fDwoMZPM130_provenance.
- NP399862.RAC4qxOCHeZ5jmmQUifTGU_vXkVIRGLfAv5o5fDwoMZPM130_assertion evidence source_evidence_literature NP399862.RAC4qxOCHeZ5jmmQUifTGU_vXkVIRGLfAv5o5fDwoMZPM130_provenance.
- NP399862.RAC4qxOCHeZ5jmmQUifTGU_vXkVIRGLfAv5o5fDwoMZPM130_assertion SIO_000772 14613973 NP399862.RAC4qxOCHeZ5jmmQUifTGU_vXkVIRGLfAv5o5fDwoMZPM130_provenance.
- NP399862.RAC4qxOCHeZ5jmmQUifTGU_vXkVIRGLfAv5o5fDwoMZPM130_assertion wasDerivedFrom befree-20150227 NP399862.RAC4qxOCHeZ5jmmQUifTGU_vXkVIRGLfAv5o5fDwoMZPM130_provenance.
- NP399862.RAC4qxOCHeZ5jmmQUifTGU_vXkVIRGLfAv5o5fDwoMZPM130_assertion wasGeneratedBy ECO_0000203 NP399862.RAC4qxOCHeZ5jmmQUifTGU_vXkVIRGLfAv5o5fDwoMZPM130_provenance.